AJP - Gastrointestinal and Liver Physiology, Vol 263, Issue 5 659-G664, Copyright © 1992 by American Physiological Society

ARTICLES

Neurokinin3 receptor regulation of acetylcholine release from myenteric plexus

W. M. Yau, K. G. Mandel, J. A. Dorsett and M. L. Youther
Department of Physiology, School of Medicine, Southern Illinois University, Carbondale 62901-6512.

This study sought to characterize the action of neurokinin B (NKB) and senktide, a selective synthetic agonist for NK3 receptors, on the myenteric plexus of the guinea pig small intestine. Both peptides stimulated a dose-dependent release of [3H]-acetylcholine (ACh). The mean effective dose values were 1 x 10(-9) for NKB and 3 x 10(-11) M for senktide. The action of these two neurokinins was blocked by the removal of Ca2+ and was sensitive to tetrodotoxin. The release of [3H]ACh was antagonized by omega-conotoxin GVIA, implying the involvement of N-type voltage-sensitive calcium channels. Senktide-evoked ACh release was also insensitive to nifedipine or flunarizine but was blocked by diltiazem. Treatment with protein kinase C (PKC) inhibitors (H-7 and polymyxin B) or activators (12-tetradecanoylphorbol 13-acetate and SC-9) failed to alter the NK3 receptor-mediated ACh output. Our data did not support an action mediated via PKC upon the activation of NK3 receptors on myenteric cholinergic neurons.

This article has been cited by other articles:

				D. P. Poole, S. Amadesi, E. Rozengurt, M. Thacker, N. W. Bunnett, and J. B. Furness Stimulation of the neurokinin 3 receptor activates protein kinase C{varepsilon} and protein kinase D in enteric neurons Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1245 - G1256. [Abstract] [Full Text] [PDF]

				D. W. P. Hay, G. A. M. Giardina, D. E. Griswold, D. C. Underwood, C. J. Kotzer, B. Bush, W. Potts, P. Sandhu, D. Lundberg, J. J. Foley, et al. Nonpeptide Tachykinin Receptor Antagonists. III. SB 235375, a Low Central Nervous System-Penetrant, Potent and Selective Neurokinin-3 Receptor Antagonist, Inhibits Citric Acid-Induced Cough and Airways Hyper-reactivity in Guinea Pigs J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 314 - 323. [Abstract] [Full Text] [PDF]

				W. L. Rumsey, D. Aharony, R. A. Bialecki, B. M. Abbott, H. G. Barthlow, R. Caccese, S. Ghanekar, D. Lengel, M. McCarthy, B. Wenrich, et al. Pharmacological Characterization of ZD6021: A Novel, Orally Active Antagonist of the Tachykinin Receptors J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 307 - 315. [Abstract] [Full Text]

				K. McConalogue, C. U. Corvera, P. D. Gamp, E. F. Grady, and N. W. Bunnett Desensitization of the Neurokinin-1 Receptor (NK1-R) in Neurons: Effects of Substance P on the Distribution of NK1-R, Galpha q/11, G-Protein Receptor Kinase-2/3, and beta -Arrestin-1/2 Mol. Biol. Cell, August 1, 1998; 9(8): 2305 - 2324. [Abstract] [Full Text]

				E. F. Grady, P. Baluk, S. Bohm, P. D. Gamp, H. Wong, D. G. Payan, J. Ansel, A. L. Portbury, J. B. Furness, D. M. McDonald, et al. Characterization of Antisera Specific to NK1, NK2, and NK3 Neurokinin Receptors and their Utilization to Localize Receptors in the Rat Gastrointestinal Tract J. Neurosci., November 1, 1996; 16(21): 6975 - 6986. [Abstract] [Full Text] [PDF]